Fermenta Biotech Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 04-10-2024
- Paid Up Capital ₹ 18.19 Cr
as on 04-10-2024
- Company Age 38 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Satisfied Charges ₹ 29.58 Cr
as on 04-10-2024
- Revenue 33.56%
(FY 2019)
- Profit 56.84%
(FY 2019)
- Ebitda 55.68%
(FY 2019)
- Net Worth 65.38%
(FY 2019)
- Total Assets 61.60%
(FY 2019)
About Fermenta Biotech
- CIN/LLPIN
U99999MH1986PLC134021
- Company No.
134021
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Jul 1986
- Date of AGM
08 Jul 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Fermenta Biotech Limited offer?
Fermenta Biotech Limited offers a wide range of products and services, including Antibacterial Drugs, Penicillin G Injections, Vitamin Powder API, Vitamin D3 Powder, Data Entry & Data Processing Service, Data Management, API (Active Pharmaceutical Ingredients), Turnkey Consultants & Solutions, Project Report Services, Anti Infective Drugs & Medicines.
Who are the key members and board of directors at Fermenta Biotech?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Nadimpally  | Managing Director | 04-Oct-2004 | Current |
| Prashant Nagre | CEO | 12-Sep-2013 | Current |
| Amol Lone | CFO | 01-Jun-2017 | Current |
| Varadvinayak Khambete | Company Secretary | 27-Feb-2017 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Krishna Vasantkumar | Director | 01-Feb-2002 | Current |
| Gopakumar Nair | Director | 06-Aug-2014 | Current |
| Anupama Desai | Whole-Time Director | 29-Mar-2007 | Current |
| Sanjay Ramakant | Director | 22-Jan-2010 | Current |
Financial Performance and Corporate Structure Insights of Fermenta Biotech.
Fermenta Biotech Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 33.56% increase. The company also saw a substantial improvement in profitability, with a 56.84% increase in profit. The company's net worth Soared by an impressive increase of 65.38%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fermenta Biotech?
In 2019, Fermenta Biotech had a promoter holding of 91.26% and a public holding of 8.73%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Fermenta Biotech LimitedActive 73 years 7 monthsKrishna Vasantkumar, Satish Nadimpally and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Aug 2018 | ₹3.07 Cr | Satisfied |
Dbs Bank Ltd Creation Date: 26 Jul 2016 | ₹1.00 Cr | Satisfied |
Siemens Financial Services Private Limited Creation Date: 17 Jul 2014 | ₹9.00 M | Satisfied |
How Many Employees Work at Fermenta Biotech?
Unlock and access historical data on people associated with Fermenta Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fermenta Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fermenta Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
